Can eye movement therapy ease trauma in thyroid cancer patients?

NCT ID NCT07447089

Recruiting now Symptom relief Sponsor: Università Cattolica di Milano Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing whether a therapy called EMDR (eye movement desensitization and reprocessing) can help reduce post-traumatic stress and psychological distress in people with advanced thyroid cancer. The study will enroll 25 participants who have cancer and PTSD symptoms. They will receive group and individual EMDR sessions. The goal is to see if this approach is feasible and helpful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EMDR therapy (eye movement desensitization and reprocessing)
What this could lead to: If it works, this could offer a way to reduce PTSD and psychological distress in people with advanced thyroid cancer.
What could go wrong: This is a very small pilot study with only 25 participants, so results may not apply to everyone. It is early-stage research, not a proven treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm post-traumatic stress disorder thyroid cancer Thyroid Neoplasms thyroid tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASM POST-TRAUMATIC STRESS DISORDER (PTSD) PSYCHOLOGICAL DISTRESS THYROID NEOPLASMS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Università Cattolica del Sacro Cuore
RECRUITING

Milan, 20123, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.